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Abstract
Background  and  objectives:  The  intense  trauma  response  triggered  by  cardiopulmonary  bypass
can lead  to  increased  morbidity  and  mortality.  The  present  study  evaluated  whether  clonidine,
a  drug  of  the  class  of  -2  agonists,  administered  by  spinal  route,  without  association  with  local
anesthetics  or  opioids,  reduces  this  response  in  cardiac  surgery  with  cardiopulmonary  bypass.
Method:  A  total  of  27  patients  between  18  and  75  years  old,  divided  by  non-blinded  fashion  into
a  control  group  (15)  and  a  clonidine  group  (12),  were  studied.  All  patients  underwent  identical
technique  of  general  anesthesia.  Then,  only  the  clonidine  group  received  1  g  kg−1 clonidine  by
spinal  route.  Levels  of  blood  glucose,  lactate  and  cortisol  were  measured  at  three  consecutive
times:  T1,  at  the  time  of  installation  of  invasive  arterial  pressure;  T2,  10  min  after  the  ﬁrst
dose  for  cardioplegia;  and  T3,  at  the  time  of  skin  suture;  and  troponin  I  values  at  T1  and  T3.
The  variation  of  results  between  T2--T1,  T3--T2,  and  T3--T1  was  also  evaluated.
Results: There  was  a  statistically  signiﬁcant  difference  only  with  respect  to  the  variation  in
blood  glucose  in  the  clonidine  group:  T3--T2,  p  =  0.027  and  T3--T1,  p  =  0.047.
Conclusions:  Spinal  clonidine  at  a  dose  of  1  g  kg−1 did  not  decrease  blood  measurements  of
troponin, cortisol,  or  lactate.  Blood  glucose  suffered  a  more  moderate  variation  during  the
procedure  in  the  clonidine  group.  This  fact,  already  reported  in  the  literature,  requires  further
investigation  to  be  clariﬁed.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  
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Clonidina;
Estresse  traumático;
Cirurgia cardíaca
Clonidina  subaracnóidea  e resposta  ao  trauma  em  cirurgias  cardíacas  com  circulac¸ão
extracorpórea
Resumo
Justiﬁcativa  e  objetivos:  A  intensa  resposta  ao  trauma  desencadeada  pela  circulac¸ão  extracor-
pórea pode  conduzir  ao  aumento  da  morbimortalidade.  O  presente  estudo  avaliou  se  a  clonidina,
 Study conducted at the Graduate Program in Clinical Surgery, Hospital de Clinicas, Universidade Federal do Paraná (UFPR).
∗ Corresponding author.
E-mail: hcgissi@gmail.com (C.G.R. Ferreira).
0104-0014      ©  2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  
http://dx.doi.org/10.1016/j.bjane.2013.04.012
Este é um artigo Open Access sob a licença de CC BY-NC-ND
396  C.G.R.  Ferreira,  S.B.  Tenório
fármaco  da  classe  dos  -2  agonistas,  por  via  raquidiana,  sem  associac¸ão  com  anestésicos  locais
ou  opioides,  reduz  essa  resposta  em  cirurgias  cardíacas  com  uso  de  circulac¸ão  extracorpórea.
Método: Estudaram-se  27  pacientes  entre  18  e  75  anos,  separados  de  modo  não  encoberto  em
grupo  controle  (15)  e  grupo  clonidina  (12).  Todos  foram  submetidos  a  técnica  idêntica  de  aneste-
sia  geral.  A  seguir,  apenas  o  grupo  clonidina  recebeu  1  mg.kg−1 de  clonidina  por  via  raquidiana.
Foram  dosados  os  valores  de  glicemia,  lactato  e  cortisol  em  três  tempos  consecutivos:  T1,  no
momento  da  instalac¸ão  da  pressão  arterial  invasiva  (PAM);  T2,  dez  minutos  após  a  primeira
dose  de  cardioplegia;  e  T3  na  sutura  da  pele,  bem  como  os  valores  de  troponina  I  em  T1  e  T3.
Avaliou-se  também  a  variac¸ão  dos  resultados  entre:  T2-T1;  T3-T2  e  T3-T1.
Resultados: Houve  diferenc¸a estatisticamente  signiﬁcativa  apenas  quanto  à  variac¸ão  da
glicemia no  grupo  clonidina:  T3-T2  valor  de  p=0,027  e  T3-T1  valor  de  p  =  0,047.
Conclusões: A  clonidina  espinhal  em  dose  de  1  g.kg−1 não  diminuiu  as  dosagens  sanguíneas  de
troponina, cortisol  ou  lactato.  A  glicemia  sofreu  uma  menor  variac¸ão  durante  o  procedimento
no  grupo  clonidina.  Esse  fato,  já  registrado  na  literatura,  necessita  de  maiores  investigac¸ões
para  ser  esclarecido.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  
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urgical  procedures  induce  an  endocrine,  metabolic  and
nﬂammatory response  in  the  body  that  causes  early  and
ate changes  in  homeostasis  with  protein  catabolism.  These
hanges are  directly  related  to  the  intensity  of  the  surgical
rauma induced.1
Although  this  set  of  physiological  changes  have  a  biolog-
cal function  to  facilitate  the  healing  of  injured  tissue  when
he aggression  is  intense  and  prolonged,  as  occurs  in  major
urgeries, the  response  to  trauma  becomes,  in  itself,  a  cause
f increased  morbidity  and  mortality.2
Patients  undergoing  cardiac  surgery  with  cardiopul-
onary bypass  (CPB)  are  subject  to  various  forms  of  aggres-
ion, such  as  the  exposure  of  blood  to  the  non-physiological
nvironment of  CPB  circuits,  acute  hemodilution  and
ctivation of  the  coagulation  cascade  and7 the  complement
ystem. As  expected,  many  of  these  patients  undergo
ntense physiological  changes  that  may  persist  for  several
ays.2,3 The  systemic  use  of  high  doses  of  opioids  and  the
euraxial blockade  with  a  local  anesthetic  seem  to  be
ble to  modulate  this  neuroendocrine  response  to  surgical
tress. Both  techniques,  however,  have  their  drawbacks,
uch as  the  respiratory  depression  prolonged  by  opioids  and
he hypotension  triggered  by  neuraxial  blockade.4,5
Clonidine,  a  drug  belonging  to  the  class  of  -2  agonists,
as been  associated  with  anesthetic-surgical  procedures
ecause of  its  ability  to  promote  hemodynamic  stability,6
o  prolong  the  analgesia  time  of  local  anesthetics  and  to
ct in  the  treatment  of  postoperative  pain.8,9 In  addition,
lonidine revealed  the  ability  to  modulate  the  response  to
urgical stress  and  a  signiﬁcant  application  in  the  treatment
f chronic  pain.10--13 Some  studies  also  suggest  that  cloni-
ine acts  to  reduce  perioperative  morbidity  and  mortality
n patients  at  risk  for  coronary  disease.14,15
Numerous  studies  have  shown  that  clonidine,  when  com-
ined with  local  anesthetics  and  opioids  by  spinal  route,
lays a  role  potentiating  their  actions.  However,  spinal  cloni-
ine, as  single  drug,  has  been  scarcely  studied.  This  research
ims to  assess  the  role  of  clonidine  in  the  endocrine-
etabolic stress  response  in  adult  patients  undergoing
w
o
(
dardiac  surgery  with  CPB,  with  the  use  of  troponin  I,  blood
lucose, lactate  and  cortisol  as  markers.
ethod
ll  patients  underwent  a  similar  technique  for  gen-
ral anesthesia,  with  puncture  of  two  peripheral  veins,
eripheral arterial  catheter  and  induction  of  general
nesthesia with  etomidate  0.2--0.5  mg  kg−1 or  propofol
.0--2.5 mg  kg−1, fentanyl  up  to  5  g  kg−1 and  pancuro-
ium or  vecuronium  0.1  mg  kg−1.  Maintenance  of  anesthesia
as performed  with  fentanyl  at  a  maximum  total  dose  of
5 g  kg−1,  distributed  during  the  procedure,  isoﬂurane  at
 maximum  concentration  of  2.5%  and  repetition  of  neu-
omuscular blocker  as  needed.  Vasoactive  drugs  could  be
sed at  any  time  at  the  discretion  of  the  anesthesiolo-
ist.
The study  excluded  patients  with  contraindications  to
pinal block,  history  of  acute  myocardial  infarction  within
he past  six  months,  emergency  surgery  and  use  of  cortico-
teroids or  clonidine.
The  patients  allocated  to  the  clonidine  group  were  placed
n lateral  decubitus  position  and  underwent  lumbar  puncture
ith disposable  needle  25  G  type  Quincke,  immediately  after
racheal intubation.  As  soon  as  the  liquor  ﬂowed  through  the
eedle, 1  g  kg−1 clonidine  was  administered,  using  a  1-mL
yringe. An  interval  of  at  least  one  hour  between  lumbar
uncture and  heparin  administration  was  observed.  Subse-
uently, urinary  catheterization  and  installation  of  a  central
enous catheter  were  performed.
All  patients  were  monitored  with  continuous  ECG  with
T segment  analysis,  nasopharyngeal  temperature,  invasive
lood pressure  (MAP),  capnography,  pulse  oximetry,  urine
utput, blood  gas,  ventilatory  monitoring  with  spirometry
nd gas  analysis.
Blood for  glucose,  lactate  and  cortisol  determination
as collected  on  three  consecutive  occasions:  at  the  time
f arterial  puncture  for  invasive  blood  pressure  monitoring
T1), 10  min  after  the  ﬁrst  dose  for  cardioplegia  (T2),  and
uring skin  suture  (T3).  Troponin  I  values  at  Times  1  and
ery  with  cardiopulmonary  bypass  397
Table  1  General  characteristics  of  groups.
Control
group  (%)
Clonidine
group  (%)
Hypertension  60  67
Diabetes 13.30  16.70
Beta-blocker 60  33.30
Valve surgery  40  75.00
t
a
sSubarachnoid  clonidine  and  trauma  response  in  cardiac  surg
3  were  measured.  We  also  assessed  the  variation  in  results
between T2--T1,  T3--T2  and  T3--T1.
CPB  was  performed  with  Braile  Biomedica® or  Nipro®
equipment,  with  oxygenators  of  the  respective  brands.
For the  infusion  of  blood  from  the  CPB  machine  to  the
patient, Medtronic® or  Terumo® centrifugal  pumps  were
used. Throughout  the  period  of  CPB,  the  temperature  was
maintained above  31 ◦C.
Parametric data  were  described  as  mean,  median,
standard deviation,  and  minimum  and  maximum  values.  The
groups were  compared  using  non-parametric  Mann--Whitney
test. p-Values  lower  than  0.05  were  considered  as  statisti-
cally signiﬁcant.
Results
The  study  included  27  patients:  15  in  the  control  and  12  in
the clonidine  group.  The  mean  ages  of  the  control  group  and
of the  clonidine  group  were  52.53  ±  13.10  and  51.75  ±  14.75
years (p  =  0.885),  respectively.  The  general  characteristics
of the  groups  are  shown  in  Table  1.
l
a
Table  2  Serum  creatinine,  PS  (%),  EF  (%)  and  CPB  time  in  both  gr
Control  group  
Creatinine  (mg/dL)  1.15  ±  0.38  
PS  (%)  34.52  ±  8.39  
EF  (%)  58.81  ±  14.45  
CPB  (min)  92.27  ±  23.53  
PS, percentual shortening; EF, ejection fraction; CPB, cardiopulmonary
Table  3  Serum  cortisol  (g/dL)  at  Times  1,  2  and  3  (mean  ±  stan
Control  group  
Time  1  11.09  ±  4.93  
Time  2  7.09  ±  4.13  
Time  3  9.06  ±  5.91  
Difference  2,  1  −3.993  ±  5.386  
Difference  3,  2  1.971  ±  2.539  
Difference  3,  1  2.02  ±  7.21  
Time 1, puncture for PAM monitoring; Time 2, 10 min after ﬁrst cardiop
a Without statistical signiﬁcance.
Table  4  Blood  glucose  (mg/dL)  at  Times  1,  2  and  3  (mean  ±  stan
Control  group  
Time  1  101.4  ±  12.84  
Time  2  154.4  ±  48.69  
Time  3  176.13  ±  57.38  
Difference  2,  1  53  ±  39.86  
Difference  3,  2  21.73  ±  25.14  
Difference  3,  1  74.73  ±  48.41  
Time 1, puncture for PAM monitoring; Time 2, 10 min after ﬁrst cardiop
a Without statistical signiﬁcance.
b With statistical signiﬁcance.Coronary surgery  60  25
The  groups  were  homogenous  in  terms  of  ejection  frac-
ion, fractional  shortening  percentage,  plasma  creatinine
nd duration  of  CPB  (Table  2).
Plasma  cortisol  values  in  control  and  clonidine  groups  are
hown in  Table  3.
Blood  glucose  values  are  shown  in  Table  4.
Table 5  displays  serum  lactate  values  in  both  groups.
Troponin  values  for  the  two  groups  are  shown  in  Table  6.
There  was  no  statistical  difference  at  the  signiﬁcance
evel of  5%  for  blood  levels  of  troponin  I,  lactate,  glucose
nd cortisol  in  all  times  analyzed  in  isolation.  There  was  a
oups.
Clonidine  group  p-Value
1.09  ±  0.28  0.684
33.43  ±  9.75  0.762
60.67  ±  13.68  0.737
78.75  ±  37.13  0.260
 bypass.
dard  deviation).
Clonidine  group  p-Value
11.9  ±  4.47  0.997a
7.49  ±  3.77  0.727a
8.16  ±  2.93  0.667a
−4.009  ±  6.102  0.893a
0.818  ±  1.746  0.244a
2.93  ±  7.08  0.980a
legia; Time 3, skin suture.
dard  deviation).
Clonidine  group  p-Value
109.75  ±  24.42  0.615a
150.64  ±  22.1  0.919a
146.67  ±  36.7  0.126a
39.821  ±  23.63  0.433a
−2.83  ±  29.13  0.027b
36.92  ±  17.49  0.047b
legia; Time 3, skin suture.
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Table  5  Determination  of  serum  lactate  (mg/dL)  at  Times  1,  2  and  3  (mean  ±  standard  deviation).
Control  group  Clonidine  group  p-Value
Time  1  1.35  ±  0.55  1.68  ±  0.56  0.152a
Time  2  2.8  ±  0.98  2.64  ±  1.19  0.702a
Time  3  3.29  ±  1.39  3.16  ±  1.78  0.719a
Difference  2,  1  1.446  ±  0.947  0.895  ±  1  0.077a
Difference  3,  2  0.485  ±  0.901  0.605  ±  1  0.0761a
Difference  3,  1 1.931 ±  1.312  1.487  ±  1.715  0.126a
Time 1, puncture for PAM monitoring; Time 2, 10 min after ﬁrst cardioplegia; Time 3, skin suture.
a Without statistical signiﬁcance.
Table  6  Determination  of  troponin  I  (/dL)  at  Times  1  and  3  (mean  ±  standard  deviation).
Control  group  Clonidine  group  p-Value
Time  1  0.021  ±  0.04  0.039  ±  0.072  0.399a
Time  3  1.571  ±  2.289  1.575  ±  1.636  0.236a
Time  3,  1  1.550  ±  2.298  1.536  ±  1.657  0.299a
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a Without statistical signiﬁcance.
tatistically  signiﬁcant  difference  in  blood  glucose  variation
t times  T3--T2  (p  =  0.027)  and  T3--T1  (p  =  0.047).
iscussion
he  present  study  evaluated  the  effects  of  spinal  clonidine
n surgical  stress  response  in  patients  undergoing  cardiac
urgery with  CPB.  The  surgical  trauma  response  is  formed  by
omplex hormonal  and  metabolic  changes  that  profoundly
lter homeostasis  and  participate  in  the  morbidity  and  mor-
ality observed  in  medium  and  major  surgeries.
The  use  of  neuraxial  clonidine  in  humans  began  in  1984.16
ince  then,  numerous  studies  suggest  that  spinal  clonidine
otentiates the  effects  of  opioids  and  local  anesthetics.7,13
herefore,  when  this  association  occurs,  it  may  be  difﬁcult
o separate  the  effects  produced  only  by  clonidine.  Spinal
lonidine not  associated  with  other  drugs  or  other  forms  of
nesthesia was  the  object  of  analysis  in  a  group  of  obstetric
atients. The  patients  were  randomly  assigned  to  receive
ither 50,  100  or  200  g  of  subarachnoid  clonidine  in  the
rst stage  of  labor.  The  results  indicate  that  clonidine  has
n analgesic  action  in  the  spinal  cord.  The  authors  point
ut that  the  dose  of  100  g  offers  the  best  dose-side  effects
elation.17
It  is  known  that  the  action  of  spinal  clonidine  is  mediated
y the  activation  of  -2  receptors  in  the  substantia  gelati-
osa, with  blockage  of  potassium  conductance  of  ﬁbers  C
nd  A.18,19 The  drug  also  acts  in  the  locus  coeruleus  by  reduc-
ng the  central  release  of  norepinephrine,  with  attenuation
f the  central  sympathetic  action.16,20 Both  actions  could
ccur with  intrathecal  clonidine,  which  would  act  both  in
he dorsal  horn  of  the  spinal  cord  and  in  the  locus  coeruleus
fter migrating,  through  the  liquor  to  the  higher  centers.
here is,  therefore,  a  theoretical  basis  to  justify  a  protective
ction of  clonidine  on  stress  responses.
Troponin  I,  cortisol,  glucose  and  lactic  acid  were  the
arkers used  in  this  study  to  identify  stress  responses  andheir  modiﬁcations  by  the  intervention  of  clonidine.  These
arkers have  already  been  extensively  validated  in  previous
tudies.21--26
In  the  present  study  only  blood  glucose  exhibited  more
oderate elevation  in  the  group  receiving  spinal  clonidine.
his suggests  that  somehow  there  was  a  lower  activation
f stress  in  this  group.  One  cannot  say  that  this  glycaemic
hange has  clinical  signiﬁcance,  although  with  statistical  sig-
iﬁcance. Thus,  there  is  no  sufﬁcient  evidence  to  contend
hat clonidine  has  a protective  role  in  stress,  when  used  by
pinal route.
onclusion
here  were  no  statistically  signiﬁcant  differences  in  tro-
onin I,  cortisol  or  lactic  acid  determinations  between  the
roups. Blood  glucose  showed  a  more  moderate  increase
n the  group  receiving  spinal  clonidine.  We  conclude  that
he use  of  clonidine  at  the  spinal  dose  of  1  g  kg−1 was
ot able  to  reduce  the  intensity  of  response  to  surgical
rauma and  showed  only  modest  activity  on  glucose  lev-
ls.
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